You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science

By Isa Hudd
Saniona presented at Stockholm Corporate Finance's 17th Capital Markets Days Life Science 2026. We interviewed CEO Thomas Feldthus about, among other things, their success when it comes to partnering with pharma companies, their weigh-loss drug candidate as well as the next strategic plans forward and upcoming phase studies. See
Saniona's presentation at the Life Science Days here.
00:00 Introduction
00:22 Saniona in a nutshell
00:58 R&D focus on ion channels 01:37 Successful in partnering with pharma companies
02:31 Weigh-loss drug candidate to the market in Mexico
03:15 Next strategic steps and long-term goals